Nephrolithiasis: Clinical Trials

4 trials for Nephrolithiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Terminated 4

Follow Nephrolithiasis: new trials by email Literature Review of Nephrolithiasis trials Research Report on Nephrolithiasis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Preoperative Prophylactic Antibiotic Duration in Moderate to High Risk Ureteroscopy
Duration of antibiotics - Infections, Urinary Tract, Nephrolithiasis
Phase 4TerminatedUniversity of California, San Francisco342024-01-012026-11-12
Regional Erector Spinae Analgesic Block vs Standard of Care Undergoing Percutaneous Nephrolithotomy
4mg PF Dexamethasone, Control Test - Kidney Stone, Surgery
Phase 4TerminatedIndiana University52020-02-242021-04-23
Silodosin Versus Tamsulosin for Treatment of Ureteral Stones
Silodosin, Tamsulosin - Ureteral Calculus, Ureterolithiasis
Phase 4TerminatedAlbert Einstein Healthcare Network12013-03-012020-06-23
The Use of Intranasal Ketoralac for Pain Management (Sprix)
Intranasal Ketoralac, Placebo - Postoperative Pain Management, Urolithiasis
Phase 4TerminatedMontefiore Medical Center502012-10-012020-02-13

Narrower conditions

Kidney Calculi (3)  ·  Agnosia (1)  ·  Pain (1)  ·  Ureteral Calculi (1)  ·  Ureterolithiasis (1)  ·  Urinary Tract Infections (1)  ·  Urolithiasis (1)

Broader conditions

Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Kidney Diseases (4)  ·  Male Urogenital Diseases (4)  ·  Urogenital Diseases (4)  ·  Urologic Diseases (4)  ·  Calculi (3)  ·  Pathological Conditions, Anatomical (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Urinary Calculi (3)  ·  Urolithiasis (3)  ·  Infections (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)

Interventions

Ketorolac (1)  ·  Standard of Care (1)  ·  Tamsulosin (1)  ·  silodosin (1)

Sponsors

Albert Einstein Healthcare Network (1)  ·  Indiana University (1)  ·  Montefiore Medical Center (1)  ·  University of California, San Francisco (1)

Countries

United States (4)

Top investigators

James Gardner, MD (1)  ·  Singh Nair, MD (1)  ·  Thomas Chi, MD, MBA (1)  ·  Tim Large, MD (1)  ·  William Boroughf, DO (1)